Twist Bioscience (TWST) Competitors $25.17 -0.44 (-1.73%) As of 11:26 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TWST vs. ADPT, BEAM, CRSP, NTLA, TXG, VCYT, LEGN, ABVX, AXSM, and RNAShould you be buying Twist Bioscience stock or one of its competitors? The main competitors of Twist Bioscience include Adaptive Biotechnologies (ADPT), Beam Therapeutics (BEAM), CRISPR Therapeutics (CRSP), Intellia Therapeutics (NTLA), 10x Genomics (TXG), Veracyte (VCYT), Legend Biotech (LEGN), Abivax (ABVX), Axsome Therapeutics (AXSM), and Avidity Biosciences (RNA). These companies are all part of the "medical" sector. Twist Bioscience vs. Its Competitors Adaptive Biotechnologies Beam Therapeutics CRISPR Therapeutics Intellia Therapeutics 10x Genomics Veracyte Legend Biotech Abivax Axsome Therapeutics Avidity Biosciences Adaptive Biotechnologies (NASDAQ:ADPT) and Twist Bioscience (NASDAQ:TWST) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, media sentiment, risk and dividends. Is ADPT or TWST more profitable? Twist Bioscience has a net margin of -23.51% compared to Adaptive Biotechnologies' net margin of -59.07%. Twist Bioscience's return on equity of -29.03% beat Adaptive Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets Adaptive Biotechnologies-59.07% -60.93% -23.03% Twist Bioscience -23.51%-29.03%-21.77% Do analysts recommend ADPT or TWST? Adaptive Biotechnologies presently has a consensus price target of $12.38, indicating a potential downside of 4.51%. Twist Bioscience has a consensus price target of $49.40, indicating a potential upside of 96.30%. Given Twist Bioscience's higher probable upside, analysts clearly believe Twist Bioscience is more favorable than Adaptive Biotechnologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adaptive Biotechnologies 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.88Twist Bioscience 1 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.73 Which has preferable valuation & earnings, ADPT or TWST? Adaptive Biotechnologies has higher earnings, but lower revenue than Twist Bioscience. Twist Bioscience is trading at a lower price-to-earnings ratio than Adaptive Biotechnologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdaptive Biotechnologies$178.96M11.03-$159.49M-$0.82-15.80Twist Bioscience$312.97M4.85-$208.73M-$1.45-17.36 Does the media refer more to ADPT or TWST? In the previous week, Twist Bioscience had 7 more articles in the media than Adaptive Biotechnologies. MarketBeat recorded 16 mentions for Twist Bioscience and 9 mentions for Adaptive Biotechnologies. Adaptive Biotechnologies' average media sentiment score of 1.33 beat Twist Bioscience's score of 0.70 indicating that Adaptive Biotechnologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adaptive Biotechnologies 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Twist Bioscience 6 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders believe in ADPT or TWST? 99.2% of Adaptive Biotechnologies shares are held by institutional investors. 6.4% of Adaptive Biotechnologies shares are held by company insiders. Comparatively, 3.0% of Twist Bioscience shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has more volatility and risk, ADPT or TWST? Adaptive Biotechnologies has a beta of 1.93, indicating that its share price is 93% more volatile than the S&P 500. Comparatively, Twist Bioscience has a beta of 2.31, indicating that its share price is 131% more volatile than the S&P 500. SummaryAdaptive Biotechnologies and Twist Bioscience tied by winning 8 of the 16 factors compared between the two stocks. Get Twist Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TWST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TWST vs. The Competition Export to ExcelMetricTwist BioscienceMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.52B$3.18B$5.80B$10.16BDividend YieldN/A2.32%5.69%4.61%P/E Ratio-17.3221.4874.7325.99Price / Sales4.85301.34470.3491.76Price / CashN/A45.3337.0859.91Price / Book3.129.6312.256.31Net Income-$208.73M-$53.32M$3.28B$270.66M7 Day Performance-2.31%0.95%1.39%3.52%1 Month Performance-8.32%9.68%7.70%6.79%1 Year Performance-43.54%13.38%64.01%28.29% Twist Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TWSTTwist Bioscience4.0011 of 5 stars$25.17-1.7%$49.40+96.3%-42.3%$1.52B$312.97M-17.32990News CoverageADPTAdaptive Biotechnologies3.589 of 5 stars$13.18-1.0%$12.38-6.1%+207.3%$2.01B$178.96M-16.07790Positive NewsBEAMBeam Therapeutics3.0489 of 5 stars$16.36-2.9%$48.45+196.2%-10.7%$1.66B$60.27M-3.64510CRSPCRISPR Therapeutics3.3247 of 5 stars$51.83-2.3%$71.60+38.1%+23.0%$4.71B$37.31M-9.55460NTLAIntellia Therapeutics4.3436 of 5 stars$11.35-2.2%$29.05+156.0%-43.6%$1.22B$57.88M-2.42600Analyst RevisionTXG10x Genomics3.3771 of 5 stars$14.01-1.9%$13.54-3.3%-40.9%$1.74B$610.78M-20.011,240News CoverageAnalyst ForecastVCYTVeracyte3.8778 of 5 stars$30.34+1.3%$40.90+34.8%+5.1%$2.39B$445.76M91.94790Positive NewsLEGNLegend Biotech3.2956 of 5 stars$34.73+1.0%$74.22+113.7%-32.0%$6.41B$796.84M-39.472,609Positive NewsABVXAbivax2.3345 of 5 stars$81.03-0.7%$92.33+13.9%+631.6%$6.12BN/A0.0061News CoverageEarnings ReportAnalyst ForecastShort Interest ↑Gap DownAXSMAxsome Therapeutics4.9162 of 5 stars$121.28-0.4%$178.00+46.8%+35.1%$6.05B$385.69M-23.92380Positive NewsInsider TradeRNAAvidity Biosciences2.127 of 5 stars$46.58-4.1%$67.00+43.8%+1.2%$5.99B$10.90M-13.08190News CoverageAnalyst ForecastInsider TradeGap Up Related Companies and Tools Related Companies Adaptive Biotechnologies Alternatives Beam Therapeutics Alternatives CRISPR Therapeutics Alternatives Intellia Therapeutics Alternatives 10x Genomics Alternatives Veracyte Alternatives Legend Biotech Alternatives Abivax Alternatives Axsome Therapeutics Alternatives Avidity Biosciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TWST) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Twist Bioscience Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Twist Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TWST Stock Alerts